Exploring the Stakeholders Involved with Enabling Autologous Cell Therapies (Part 3)

How well have you mapped the stakeholders and functions involved with enabling the successful order, delivery, and infusion of your ACT product? Unlike traditional specialty products, even more sophisticated specialty therapeutics, the range of stakeholder functions involved with ACTs are much more extensive.

  In our 3rd Infographic of a five part series, we layout the key stakeholder functions that will need to be addressed/incorporated in some way into your commercialization planning. Leveraging your potential customer stakeholder functions to then explore the varied needs existing across each can then also lead to the holistic development of your customer needs sets… and your ultimate customer engagement model.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Contact Us: CellandGene@Nuveracg.com

Exploring the Experience with Autologous Cell Therapies (Part 2)

What Experience are you Designing for your #Celltherapy? Nuvera’s second infographic in a series of five focuses on highlighting how the experiences of patients, referring physicians, treatment centers, and the cells themselves relate to each other.

Mapping the details associated with the end-to-end treatment experience with ACTs is essential for a manufacturer to zero in on issues that are not only the most critical but also those they are most qualified to solve for (vs. trying to solve for everything). Our ACT Treatment Experience infographic will help shed some light on important considerations as you undertake this effort.

The ACT Treatment Experience infographic provides a broad overview of some of the areas where a biopharma manufacturer can influence the various elemental journeys with examples of inflection points requiring intervention or support in some form from your organization. Stay tuned for our next infographic which revolves around the functions and stakeholders involved across the ACT experience.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Contact Us: CellandGene@Nuveracg.com

Introducing Nuvera’s Infographic Series on Autologous Cell Therapies (Part 1)

Commercializing a CAR-T or other #Celltherapy? Nuvera is excited to share a newly developed series touching upon several commercialization issues surrounding Autologous Cell Therapies (ACTs) based upon over six years of direct experience partnering with multiple ACT manufacturers in helping to bring these amazing therapies to market.

This first installment of our series introduces several key concepts across four key ACT concepts: 1) The complexities of the overall treatment experience, 2) the multitude of stakeholders to consider, 3) steps of managing an intricate product utilization process, and finally, 4) the robust technology ecosystem required to enable commercialization.

In the coming weeks, Nuvera will share more detailed infographics aligned to the four areas described above. In the meantime, this snapshot can help stimulate potential thinking and internal dialog around where your company may need to focus next.

Note on Printing this Infographic: The optimal printing size for this graphic is 11×17 inch paper.

Who We Are: Nuvera LLC is a strategic consulting team focused exclusively on the rare disease and specialty therapeutics with over 10 years in helping our specialty pharma/biotech clients design exceptional treatment support experiences.

Contact Us: CellandGene@nuveracg.com